Chemours Co (CC) › Cash & EquivalentsChemours Co (CC) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2013: $02014: $02015: $366.00M2016: $902.00M2017: $1.56B2018: $1.20B2019: $943.00M2020: $1.10B2021: $1.45B2022: $1.10B2023: $1.20B2024: $713.00M2025: $670.00M$670.00M2013Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$670.00M-6.0%2024$713.00M-40.7%2023$1.20B+9.2%2022$1.10B-24.1%2021$1.45B+31.3%2020$1.10B+17.2%2019$943.00M-21.5%2018$1.20B-22.8%2017$1.56B+72.5%2016$902.00M+146.4%2015$366.00M—2014$0—2013$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share